| Abstrak/Abstract |
Diabetes mellitus has increased in prevalence over time and medicinal plants such as Tinospora crispa (L.) Hook.f. & Thomson is well-known for their use in hyperglycemic management. While there are several publications on T. crispa as an antidiabetic, there is a lack of bibliometric studies on this subject. The objective of this study was to conduct a bibliometric analysis of existing articles on the preclinical trial of T. crispa as an antidiabetic, with focus on countries, institutions, publishers, authors, documents, and keywords. We used the Scopus database to obtain bibliographic information of original research and conference articles related to the topic. There were 24 selected publications between 1989 and 2019. Data were analyzed bibliometrically using Vosviewer 1.6.16. Malaysia, John Radcliffe Hospital (United Kingdom), Journal of Ethnopharmacology, Hamdan Noor and Stephen J.H. Ashcroft (John Radcliffe Hospital, United Kingdom) were the most contributing countries, institutions, publishers, and authors, respectively. The analysis of the most influential papers, the co-citation network of the most influential papers, the bibliographical coupling network based on authors, and the keyword co-occurrence network and overlay revealed that the majority and diversity of existing papers on preclinical trials of T. crispa as an antidiabetic were in the fields of phytochemistry and pharmacology. Our analysis's findings impact both managerial and theoretical aspects of this topic, such as encouraging research collaboration and identifying research gaps required for herbal medicine approval (molecular mechanisms, toxicities and side effects, drug formulations, and clinical trials). |
